HARRIS JAMES E
Known title: Chief Financial OfficerCIK: 0001192813
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
SPXC receives analyst coverage and growth focus. Recent analyst notes emphasize SPX Technologies' growth profile, citing its market position and revenue trends. Oppenheimer kept an Outperform rating but adjusted its price target to $270, reflecting a more modest outlook. A separate piece highlighted the compound return of a $100 investment over 15 years, underscoring the stock’s long‑term performance while it trades near the lower end of its 52‑week range.
Transaction History
| RXO | ▲ Buy | Option Exercise | 64,129 | $0 | 9/26/2026 | View on chart |
| RXO | ▼ Sell | Tax Withholding | 27,858 | $551K | 9/26/2026 | View on chart |
| RXO | ▲ Buy | Option Exercise | 12,989 | $0 | 3/22/2026 | View on chart |
| RXO | ▼ Sell | Tax Withholding | 5,643 | $75K | 3/22/2026 | View on chart |
| RXO | ▲ Buy | Option Exercise | 13,028 | $0 | 2/28/2026 | View on chart |
| RXO | ▼ Sell | Tax Withholding | 5,660 | $90K | 2/28/2026 | View on chart |
| RXO | ▲ Buy | Option Exercise | 21,834 | $0 | 2/23/2026 | View on chart |
| RXO | ▼ Sell | Tax Withholding | 9,808 | $144K | 2/23/2026 | View on chart |
| RXO | ▲ Buy | Option Exercise | 64,130 | $0 | 9/26/2025 | View on chart |
| RXO | ▼ Sell | Tax Withholding | 28,025 | $419K | 9/26/2025 | View on chart |
| RXO | ▲ Buy | Option Exercise | 12,989 | $0 | 3/22/2025 | View on chart |
| RXO | ▼ Sell | Tax Withholding | 5,677 | $106K | 3/22/2025 | View on chart |
| RXO | ▲ Buy | Option Exercise | 21,835 | $0 | 2/23/2025 | View on chart |
| RXO | ▼ Sell | Tax Withholding | 9,728 | $196K | 2/23/2025 | View on chart |
| RXO | ▲ Buy | Option Exercise | 32,064 | $0 | 9/26/2024 | View on chart |
| RXO | ▼ Sell | Tax Withholding | 14,093 | $384K | 9/26/2024 | View on chart |
| RXO | ▲ Buy | Option Exercise | 21,834 | $0 | 2/23/2024 | View on chart |
| RXO | ▼ Sell | Tax Withholding | 9,830 | $211K | 2/23/2024 | View on chart |
| RXO | ▲ Buy | Option Exercise | 32,065 | $0 | 9/26/2023 | View on chart |
| RXO | ▼ Sell | Tax Withholding | 14,173 | $273K | 9/26/2023 | View on chart |
| SPXC | ▼ Sell | Tax Withholding | 513 | $33K | 8/17/2022 | View on chart |
| SPXC | ▼ Sell | Tax Withholding | 431 | $22K | 3/1/2022 | View on chart |
| SPXC | ▲ Buy | Grant | 13,374 | — | 3/1/2022 | View on chart |
| SPXC | ▼ Sell | Tax Withholding | 518 | $33K | 8/17/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
RXO Stock Gains as C.H. Robinson Deal Lifts Analyst Targets
RXO Inc. is in focus after the C.H. Robinson deal anchored higher analyst price targets, with Truist Securities raising its target to $30. This development comes alongside broader transport sector discussions regarding diesel prices and small-cap valuation questions. The stock is currently trading near the top of its 52-week range, reflecting recent momentum driven by these fundamental updates.
RXO Stock Gains as C.H. Robinson Deal Lifts Analyst Targets. RXO Inc. is in focus after the C.H. Robinson deal anchored higher analyst price targets, with Truist Securities raising its target to $30. This development comes alongside broader transport sector discussions regarding diesel prices and small-cap valuation questions. The stock is currently trading near the top of its 52-week range, reflecting recent momentum driven by these fundamental updates.